1 completed, 1 enrolling by invitation, 1 recruiting. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 1, Enrolling by invitation 1, Recruiting 1 |
Follow dapirolizumab pegol: new trials by email Literature Review of dapirolizumab pegol trials Research Report on dapirolizumab pegol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus DZP, Placebo - Systemic Lupus Erythematosus | Phase 3 | Recruiting | UCB Biopharma SRL | 450 | 2024-11-21 | 2026-11-02 |
| A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus Dapirolizumab pegol - Systemic Lupus Erythematosus | Phase 3 | Enrolling by invitation | UCB Biopharma SRL | 760 | 2021-07-27 | 2026-11-13 |
| A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus DZP, Placebo - Systemic Lupus Erythematosus | Phase 3 | Completed | UCB Biopharma SRL | 321 | 2020-08-12 | 2025-05-04 |
Lupus Erythematosus, Systemic (3)
Argentina (3) · Belgium (3) · Canada (3) · Chile (3) · Germany (3) · Greece (3) · Italy (3) · Mexico (3) · Peru (3) · Poland (3) · Serbia (3) · South Korea (3) · Spain (3) · Taiwan (3) · United States (3)
2019 (3), 2023 (2)